ApoCell Awarded Contract to Develop Circulating Tumor Cell Isolation Technology (ApoStreamTM) from NCI's Division of Cancer Treatment and Diagnosis (DCTD)
ApoCell Launches Revolutionary Circulating Cancer Cell Detection System - ApoStreamTM
ApoCell Awarded $2.9M from SAIC-Frederick, Inc. to Deliver a New Platform for Detection and Molecular Analysis of Circulating Tumor Cells
ApoCell named to Inc Magazine's List of the 5000 Fastest Growing Private Companies
ApoCell named to Houston Business Journal's List of the 100 Fastest-Growing Private Companies in Houston
ApoCell awarded SBIR Grant to Develop Point of Care Device for Antibody Independent Isolation of Circulating Tumor Cells
ApoCell is located 3 miles from the world famous Texas Medical Center. The company recently renovated custom laboratory space in the Wilbury Biotechnology Center.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Receive more information or want to be on our mailing list? Please fill out the following form.
